EUVIMEDEUVIMED entdecken
Crossref

Risk factors and interrelationships of taxane-related peripheral neuropathy: a Bayesian network analysis

Huiqian Xu, Yijing Fan, Hong Li, Shufang Zhang, Lizhi Zhou, Yandong Wang

Supportive Care in Cancer · 2025

DOI: 10.1007/s00520-025-10201-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Huiqian Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: North China University of Science and Technology, Tangshan, Hebei, China. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Breast Neoplasms, Taxoids, Antineoplastic Agents. Die Arbeit nennt 37 Literaturangaben. Gefördert von: the Hebei Medical Science Research Project of 2026.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aims to investigate the factors influencing peripheral neuropathy in breast cancer patients treated with taxane-based chemotherapy and the interrelationships between these factors, providing a reference for targeted interventions. METHODS: A total of 350 breast cancer patients undergoing chemotherapy at Tangshan People's Hospital were enrolled in this study. Data were collected using a general information questionnaire, the Health-Promoting Lifestyle Profile (HPLP-II), the Hospital Anxiety and Depression Scale (HADS), the Social Support Rating Scale (SSRS), the Pittsburgh Sleep Quality Index (PSQI), the International Physical Activity Questionnaire (IPAQ), and the Fried Frailty Phenotype. The study aimed to investigate the influencing factors of chemotherapy-induced peripheral neuropathy (CIPN) and the interrelationships among these factors. RESULTS: The incidence of CIPN was 79.1%. Age, chemotherapy regimen, hypertension, depression, BMI, frailty, sleep quality, healthy lifestyle, social support, and physical activity were significant predictors (P 50 years, with BMI > 25, depression, hypertension, and ≥ 4 chemotherapy cycles. CONCLUSION: The incidence of peripheral neuropathy in breast cancer patients treated with taxane-based chemotherapy is high. Healthcare providers should focus on high-risk populations for chemotherapy-induced peripheral neuropathy. Multidisciplinary collaboration and comprehensive interventions are essential to reduce the risk of developing peripheral neuropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Nervous System DiseasesBreast NeoplasmsTaxoidsAntineoplastic AgentsBridged-Ring CompoundsHumansFemaleMiddle AgedBayes TheoremRisk FactorsAdultAgedSurveys and QuestionnairesIncidenceAge FactorsSocial SupportDepressionBody Mass IndexSleep QualityLife StyleChina

Stichwörter der Autor:innen

Bayesian networkBreast cancerChemotherapyPaclitaxelPeripheral neuropathyRisk factors

Substanzen

TaxoidstaxaneAntineoplastic AgentsBridged-Ring Compounds

Autor:innen und Institutionen

  • North China University of Science and Technology, Tangshan, Hebei, China.
  • Tangshan People's Hospital, Tangshan, China.
  • Tangshan People's Hospital, Tangshan, China. zhoulizhi72@126.com.
  • North China University of Science and Technology, Tangshan, Hebei, China. 1405001332@qq.com.

Förderung

  • the Hebei Medical Science Research Project of 2026

Zitieren

APA

Xu, H., Fan, Y., Li, H., Zhang, S., Zhou, L., & Wang, Y. (2025). Risk factors and interrelationships of taxane-related peripheral neuropathy: a Bayesian network analysis. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-10201-9

Vancouver

Xu H, Fan Y, Li H, Zhang S, Zhou L, Wang Y. Risk factors and interrelationships of taxane-related peripheral neuropathy: a Bayesian network analysis. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-10201-9

BibTeX
@article{Xu2025,
  author = {Xu, Huiqian and Fan, Yijing and Li, Hong and Zhang, Shufang and Zhou, Lizhi and Wang, Yandong},
  title = {Risk factors and interrelationships of taxane-related peripheral neuropathy: a Bayesian network analysis},
  journal = {Supportive Care in Cancer},
  year = {2025},
  doi = {10.1007/s00520-025-10201-9}
}
Kostenlos starten →